New perspectives in regenerative medicine and surgery: the bioactive composite therapies (BACTs)

被引:11
|
作者
Zocchi, Michele L. [1 ,2 ]
Facchin, Federico [1 ]
Pagani, Andrea [3 ]
Bonino, Claudia [4 ]
Sbarbati, Andrea [5 ]
Conti, Giamaica [5 ]
Vindigni, Vincenzo [1 ]
Bassetto, Franco [1 ]
机构
[1] Univ Padua, Plast & Reconstruct Surg Unit, Padua, Italy
[2] Remix Inst Regenerat Surg, Turin, Italy
[3] Tech Univ Munich, Dept Plast & Hand Surg, Munich, Germany
[4] Humanitas Gradenigo Hosp, Dept Rheumatol & Immune Dis, Turin, Italy
[5] Univ Verona, Inst Human Anat, Verona, Italy
关键词
Minimal grade manipulation (MGM); Programmed cell death (PCD); Bioactive composite mixtures (BACMs); Adipose-derived stem cells (ADSCs); Stromal vascular fraction (SVF); Cellular components (CCs); Blood components (BCs); Platelet-rich fibrin (PRF); Amino acids (AA); Vitamins; Reduced glutathione (GSH); REMIX; Cytokine modulation; Donor site preparation; Delayed harvesting; Muse cells; Photobiostimulation; ROS antagonism; MESENCHYMAL STEM-CELLS; STROMAL-VASCULAR FRACTION; HUMAN ADIPOSE-TISSUE; MUSE CELLS; GROWTH-FACTORS; DIFFERENTIATION; PRF;
D O I
10.1007/s00238-021-01874-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Regenerative medicine and surgery is a rapidly expanding branch of translational research in tissue engineering, cellular and molecular biology. To date, the methods to improve cell intake, survival, and isolation need to comply with a complex and still unclear regulatory frame, becoming everyday more restrictive and often limiting the effectiveness and outcome of the therapeutic choices. Thus, the authors developed a novel 360 degrees regenerative strategy based on the synergic action of several new components called the bioactive composite therapies (BACTs) to improve grafted cells intake, and survival in total compliance with the legal and ethical limits of the current regulatory frame. The rationale at the origin of this new technology is based on the evidence that cells need supportive substrate to survive in vitro and this observation, applying the concept of translational medicine, is true also in vivo. Bioactive composite mixtures (BACMs) are tailor-made bioactive mixtures containing several bioactive components that support cells' survival and induce a regenerative response in vivo by stimulating the recipient site to act as an in situ real bioreactor. Many different tissues have been used in the past for the isolation of cells, molecules, and growth factors, but the adipose tissue and its stromal vascular fraction (SVF) remains the most valuable, abundant, safe, and reliable source of regenerative components and particularly of adipose-derived stems cells (ADSCs). The role of plastic surgeons as the historical experts in all the most advanced techniques for harvesting, manipulating, and grafting adipose tissue is fundamental in this constant process of expansion of regenerative procedures. In this article, we analyze the main causes of cell death and the strategies for preventing it, and we present all the technical steps for preparing the main components of BACMs and the different mixing modalities to obtain the most efficient regenerative action on different clinical and pathological conditions. The second section of this work is dedicated to the logical and sequential evolution from simple bioactive composite grafts (BACGs) that distinguished our initial approach to regenerative medicine, to BACTs where many other fundamental technical steps are analyzed and integrated for supporting and enhancing the most efficient regenerative activity. Level of Evidence: Not gradable
引用
收藏
页码:1 / 25
页数:25
相关论文
共 50 条
  • [1] New perspectives in regenerative medicine and surgery: the bioactive composite therapies (BACTs)
    Michele L. Zocchi
    Federico Facchin
    Andrea Pagani
    Claudia Bonino
    Andrea Sbarbati
    Giamaica Conti
    Vincenzo Vindigni
    Franco Bassetto
    [J]. European Journal of Plastic Surgery, 2022, 45 : 1 - 25
  • [2] Bioactive nanostructures for regenerative medicine and cancer therapies
    Stupp, S. I.
    [J]. TISSUE ENGINEERING PART A, 2008, 14 (05) : 703 - 703
  • [3] Regenerative Medicine: Challenges and Perspectives for Successful Therapies
    Viswanathan, S.
    Joshi, C.
    [J]. NEW PERSPECTIVES IN REGENERATION, 2013, 367 : 101 - 112
  • [4] CURRENT PERSPECTIVES, CHALLENGES AND ADVANCES IN REGENERATIVE MEDICINE THERAPIES
    Allickson, Julie
    [J]. TISSUE ENGINEERING PART A, 2022, 28 : S644 - S645
  • [5] Cell therapies and regenerative medicine
    Blum, Hubert E.
    [J]. HEPATOLOGY INTERNATIONAL, 2014, 8 (02) : 158 - 165
  • [6] Cell therapies and regenerative medicine
    Hubert E. Blum
    [J]. Hepatology International, 2014, 8 : 158 - 165
  • [7] Novel perspectives on the role of the human microbiota in regenerative medicine and surgery
    Pellegatta, Tommaso
    Saler, Marco
    Bonfanti, Viola
    Nicoletti, Giovanni
    Faga, Angela
    [J]. BIOMEDICAL REPORTS, 2016, 5 (05) : 519 - 524
  • [8] Tissue engineering and regenerative medicine research perspectives for pediatric surgery
    Amulya K. Saxena
    [J]. Pediatric Surgery International, 2010, 26 : 557 - 573
  • [9] Tissue engineering and regenerative medicine research perspectives for pediatric surgery
    Saxena, Amulya K.
    [J]. PEDIATRIC SURGERY INTERNATIONAL, 2010, 26 (06) : 557 - 573
  • [10] Autobionics: a new paradigm in regenerative medicine and surgery
    Ashrafian, Hutan
    Darzi, Ara
    Athanasiou, Thanos
    [J]. REGENERATIVE MEDICINE, 2010, 5 (02) : 279 - 288